Sangamo Therapeutics, Inc. (SGMO)

Sangamo Therapeutics Revenue

Sangamo Therapeutics had revenue of $581.00K in the quarter ending September 30, 2025, a decrease of -98.82%. This brings the company's revenue in the last twelve months to $32.88M, down -37.13% year-over-year. In the year 2024, Sangamo Therapeutics had annual revenue of $57.80M, down -67.20%.

• Revenue (ttm): $32.88M
• Revenue Growth: -37.13%
• P/S Ratio: 3.36
• Revenue / Employee: $179,645
• Employees: 183
• Market Cap: 149.64M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	57.80M	-118.43M	-67.20%
Dec 31, 2023	176.23M	64.93M	58.34%
Dec 31, 2022	111.30M	598.00K	0.54%
Dec 31, 2021	110.70M	-7.49M	-6.34%
Dec 31, 2020	118.19M	15.76M	15.39%